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ABSTRACT 1 
Cellular hypoxia triggers a homeostatic increase in mitochondrial free radical 2 
signalling. In this study, blood was obtained from the radial artery and jugular venous 3 
bulb in ten males during normoxia and 9h hypoxia (12.9%O2). Mitochondrial oxygen 4 
tension (
_
P mitO2 ) was derived from cerebral blood flow and blood gases. The ascorbate 5 
radical (A•-) was detected by electron paramagnetic resonance spectroscopy and 6 
neuron-specific enolase (NSE), a biomarker of neuronal injury, by ELISA. Hypoxia 7 
increased the cerebral output of A•- in proportion to the reduction in 
_
P mitO2  but did not 8 
affect NSE exchange. These findings suggest that neuro-oxidative stress may 9 
constitute an adaptive response. 10 
11 
 3 
INTRODUCTION 1 
Although the human brain represents only 2% body weight it accounts for a 2 
disproportionate 25% of basal oxygen (O2) consumption to support the demands of 3 
neuronal activity. This commitment to an obligatory high rate of O2 consumption 4 
combined with limited glycolytic capacity renders the brain exquisitely sensitive to O2 5 
deprivation (hypoxia) with a correspondingly high vulnerability for failure (Bailey et 6 
al 2009a). As a consequence, elaborate cellular O2-sensing mechanisms have evolved 7 
to preserve O2 homeostasis and ultimately prevent brain damage (Sharp and 8 
Bernaudin 2004).  9 
However, despite considerable progress in our understanding of the cerebral pathways 10 
activated during hypoxia, a unified mechanism that allows the brain to sense and 11 
ultimately respond to O2 remains elusive. Emerging evidence suggests that the  12 
mitochondrion may function as the primary O2 “sensor” given its capacity to increase 13 
free radical and associated reactive oxygen-nitrogen species (ROS-RNS) formation 14 
during hypoxia (Chandel et al 1998). Though thermodynamically capable of causing 15 
structural damage when in excess, these oxidant signals can act as second messengers 16 
(Wright et al 2004) that activate O2 salvage genes through stabilization of the 17 
transcription factor hypoxia-inducible factor (HIF)-1α (Guzy and Schumacker 2006) 18 
in physiologically controlled though as of yet undefined amounts.  19 
In support, human studies have documented an increased systemic formation of free 20 
radicals during hypoxia in proportion to arterial desaturation (Bailey et al 2009b). 21 
However, whether any potential relationship exists between cerebral mitochondrial 22 
PO2 and the focal (cerebral) formation of free radicals remains to be examined. This is 23 
clinically relevant given the cerebral complications encountered in diseases defined 24 
 4 
by hypoxemia, notably obstructive sleep apnea and chronic obstructive pulmonary 1 
disease (Sharp and Bernaudin 2004).   2 
To investigate this, we combined electron paramagnetic resonance (EPR) 3 
spectroscopy for direct detection of the abscorbate radical (A•-) with calculation of 4 
cerebral mitochondrial PO2 (
_
P mitO2 ) in a group of healthy volunteers exposed to 5 
hypoxia. We hypothesized that compared to normoxia, hypoxia would promote the 6 
cerebral formation and net output of A•- as indicated by a negative arterio-jugular 7 
venous concentration difference (a-jvD). Since we considered this to reflect an 8 
adaptive response that preserves O2 homeostasis, we further hypothesized that A•- 9 
output would correlate against the reduction in
_
P mitO2  in the absence of neurovascular 10 
tissue damage as indicated by a lack of exchange in the neuronal-parenchymal injury 11 
biomarker, neuron-specific enolase (NSE). 12 
 13 
 14 
 15 
 16 
 17 
 18 
 19 
20 
 5 
METHODS 1 
Subjects and design 2 
Ten males aged 27 ± 4 years old provided written informed consent following 3 
approval by the Scientific Ethics Committee of Copenhagen and Frederiksberg 4 
Municipalities (Denmark). Following local anesthesia (2% lidocaine), subjects 5 
received a retrograde catheter in the right internal jugular vein via the Seldinger 6 
technique under ultrasound guidance with the tip advanced to the bulb of the vein. A 7 
radial arterial catheter was placed in the non-dominant arm. Baseline samples were 8 
collected in normoxia (21%O2) and after 9h passive exposure to hypoxia (12.9%O2).    9 
 10 
Cerebral oxygenation 11 
Hemoglobin (Hb), hematocrit (Hct), partial pressure of oxygen and carbon dioxide 12 
(PO2/PCO2), oxyhemoglobin saturation (SO2), pH, P50, temperature and (whole-13 
blood) glucose were determined using a blood gas analyzer (ABL 715 Radiometer 14 
Medical, Denmark). Global cerebral blood flow (CBF) was measured via the Kety-15 
Schmidt technique in the de-saturation mode using nitrous oxide (N2O) as the tracer 16 
(Taudorf et al 2009). Briefly, subjects inhaled 5% N2O and O2 in N2 (corresponding 17 
to both normoxic and hypoxic inspirates) for 30 minutes. From two minutes before 18 
the cessation of N2O until 15 minutes thereafter, 12 sets of paired synchronized 19 
samples were drawn into gas-tight syringes from the arterial and venous catheters. 20 
Samples equilibrated against air in a water bath at 37ºC for 60 minutes and N2O 21 
concentration measured via photoacoustic spectroscopy (Innova Photoacoustic Field 22 
Gas Monitor 1412, Brüel & Kjaer, Denmark). Unlike our previous study (Taudorf et 23 
al 2009), all tubing was pre-saturated with a syringe filled with pure N2O, O2 and N2 24 
 6 
corresponding to the inspired air mixtures prior to running experimental samples. 1 
Global CBF was subsequently derived by the Kety-Schmidt equation given as: 2 
 3 
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 7 
where cjv (t) and ca (t) are the jugular venous and arterial concentration of the tracer at 8 
time (t) in min and λ represents the brain-blood partition coefficient (ml/g) calculated 9 
from data reported previously (Kety et al 1948): 10 
 11 
λ = 1.167 – [0.0026 x Hct (%)] 12 
 13 
Cerebral plasma flow (CPF) was calculated as CBF x (1-Hct). Cerebral O2 delivery 14 
was calculated as: 15 
 16 
CBF x caO2 17 
 18 
where caO2 refers to arterial oxygen content (mmol): 19 
 20 
caO2 = 0.60 x SaO2 x Hb + 0.0013 x PaO2 21 
 22 
 23 
 7 
The oxygen extraction fraction (EO2) was determined by: 1 
 2 
EO2 = (%)100
2
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a
va −  3 
 4 
The global cerebral metabolic rate of oxygen (CMRO2) was calculated as: 5 
 6 
CMRO2 = CBF x a-jvDO2 7 
 8 
where a-jvDO2 refers to the arterio-jugular venous O2 content difference. 9 
 10 
The oxygen-glucose index (OGI) was calculated as: 11 
 12 
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 14 
Using established formalism (Gjedde 2005; Gjedde et al 2005; Rasmussen et al 15 
2007), the mean capillary oxygen saturation (
_
S capO2 ) was calculated as: 16 
 17 
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assuming that O2 extraction rises linearly with distance as blood traverses the 20 
capillary network. Solution of the Hill equation permitted calculation of the (mean) 21 
capillary PO2 (
_
P capO2 ):   22 
 8 
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where HbaP50 is the PO2 when Hb is half-saturated (29 mmHg) and ah is Hill’s coefficient 3 
(2.84 for arterial blood). Given the absence of capillary recruitment in the brain, O2 4 
diffusibility (L) was calculated during hypoxia (in which the 5 
mitochondrial oxygen tension could be assumed to be negligible) and given as:  6 
 7 
L = −
cap
OP 2
2CMRO  8 
 9 
based on group mean values and assumed to be constant at 7.8 µmol 100g-1min-10 
1mmHg-1 for any given CBF. The mean mitochondrial PO2 (
_
P mitO2 ) was subsequently 11 
given by: 12 
 13 
_
P mitO2  = 
_
P capO2  - L
CMRO2    14 
 15 
The assumptions and limitations associated with the formalism underlying the 16 
nonlinear flow-metabolism coupling model have been discussed in detail elsewhere 17 
(Gjedde 2005). 18 
 19 
 20 
 21 
 9 
Ascorbate (antioxidant) 1 
Exactly 100 µL of plasma was stabilized and deproteinated by adding 900 µL of 5% 2 
metaphosphoric acid (Sigma Chemical, Dorset, UK).  Ascorbate was assayed by 3 
fluorimetry based on the condensation of dehydroascorbic acid with 1,2-4 
phenylenediamine (Bailey et al 2009d). The intra- and inter-assay CV were both <5 5 
%.  6 
 7 
Ascorbate (free radical) 8 
Exactly 1mL of plasma was injected into a high-sensitivity multiple-bore sample cell 9 
(AquaX, Bruker Instruments Inc, Billerica, USA) housed within a TM110 cavity and 10 
analyzed by X-band EPR spectroscopy operating at 100 kHz modulation frequency, 11 
0.65 Gauss (G) modulation amplitude, 10 mW microwave power, 2 x 105 receiver 12 
gain and 41 ms time constant for 3 incremental scans (Bailey et al 2009b). Spectra 13 
were filtered identically using WINEPR (Version 2.11) and the double integral of 14 
each doublet was calculated using Origin software (Version 5.0). The intra- and inter-15 
assay CV were both <5 %.  16 
 17 
Neuron specific enolase (NSE) 18 
NSE was incorporated as a molecular biomarker of neuronal-parenchymal injury 19 
using a commercially available ELISA (CanAg, Ref 420-10) with a lower detection 20 
limit of <1µg/L. The intra and inter-assay CV were both <5 %. 21 
 22 
 23 
 24 
 25 
 10 
Cerebral net exchange 1 
This was calculated as: 2 
 3 
CPF x a-jvD 4 
 5 
By convention, a negative value reflects net cerebral output or gain whereas a positive 6 
value reflects consumption or loss.  7 
 8 
Cephalalgia 9 
Symptoms of acute mountain sickness (AMS) were assessed using the Lake Louise 10 
(LL) (Roach et al 1993) and Environmental Symptoms Questionnaire Cerebral (ESQ-11 
C) (Sampson et al 1983) scoring systems. A clinically-validated visual analog scale 12 
(VAS) was employed to measure headache (Iversen et al 1989). Clinical AMS was 13 
diagnozed if a subject presented with a combined total LL score (self assessment + 14 
clinical score) of ≥ 5 points and ESQ-C score ≥ 0.7 points (Bailey et al 2009b). 15 
 16 
Statistical Analysis 17 
Shapiro-Wilk W tests confirmed distribution normality. Cerebral oxygenation and 18 
exchange data were analyzed using a combination of paired samples t-tests and 2-way 19 
repeated measures ANOVA. Relationships were examined using a Pearson Product 20 
Moment Correlation. Significance was established at P < 0.05 and data are presented 21 
as mean ± SD. 22 
23 
 11 
RESULTS  1 
Cerebral oxygenation 2 
Hypoxia was associated with a reduction (P < 0.05 vs. normoxia) in PaO2 (107 ± 6 to 3 
46 ± 3 mmHg), PaCO2 (43 ± 2 to 35 ± 2 mmHg), SaO2 (99 ± 1 to 83 ± 3 %), and 4 
corresponding cerebral O2 delivery (Table 1). As a consequence,
_
S capO2 , 
_
P capO2  and 
_
P mitO2  5 
were also shown to decrease. An increase in EO2 and (tendency towards) CBF 6 
counteracted hypoxemia thus preserving CMRO2. By contrast, the OGI was not 7 
altered during hypoxia (6.11 ± 0.79 vs. 5.86 ± 0.95 in normoxia, P > 0.05). 8 
 9 
Free radicals 10 
Hypoxia did not affect the a-jvD or subsequent exchange of ascorbate (hypoxia: 0.052 11 
± 0.250 vs. normoxia: 0.120 ± 0.249 mM 100g-1 min-1, P > 0.05). In contrast, hypoxia 12 
decreased the a-jvD of A•- (-522 ± 471 vs. -148 ± 256 AU 100g-1, P < 0.05) due 13 
primarily to an increase in jugular venous outflow (P < 0.05). Typical examples of A•- 14 
spectra (aH4 ≈1.76 G, ∆Hpp = ≈0.6G and g = 2.0052) observed with corresponding 15 
signal intensities are illustrated in Figure 1A. This translated into an increased 16 
cerebral output in hypoxia (-29283 ± 25852 vs. -7131 ± 12260 AU 100g-1min-1, P < 17 
0.05) which correlated directly against the reduction in 
_
P mitO2  (Figure 1B). 18 
 19 
Neurovascular integrity  20 
There was no evidence of neuronal-parenchymal injury since hypoxia affected neither 21 
the a-jvD nor the exchange of NSE (34.6 ± 40.2 vs. normoxia: 30.2 ± 36.3 µg 100g-22 
1min-1, P > 0.05). 23 
 24 
 12 
Cephalalgia 1 
Hypoxia increased AMS (LL: 3 ± 2 vs. normoxia: 0 ± 0 points, P < 0.05; ESQ-C: 2 
0.803 ± 0.674 vs. normoxia: 0.000 ± 0.000 AU, P < 0.05) and headache (VAS: 29 ± 3 
23 vs. normoxia: 0 ± 0 mm, P < 0.05) scores which correlated modestly against the 4 
increased cerebral output of A•-  (LL: r = -0.61, P = 0.06; ESQ-C: r = -0.56, P = 0.09; 5 
VAS: r = -0.65, P = 0.04). Furthermore, the one subject diagnozed with clinical AMS 6 
exhibited the greatest reduction in 
_
P mitO2  (-30.9 mmHg) and increase in the a-jvD (-7 
1334 AU 100g-1) and subsequent cerebral output of A•- (-75424 AU 100g-1min-1) 8 
during hypoxia. 9 
 10 
 11 
12 
 13 
DISCUSSION 1 
The major finding in the present study was that the increased cerebral output of free 2 
radicals in the form of A•- observed during hypoxia did not compromize neuronal-3 
parenchymal integrity and correlated directly against the reduction in
_
P mitO2 . While this 4 
does not disassociate cause from effect, it points towards an adaptive mechanism by 5 
which mitochondria potentially “sense” changes in cerebral O2 tension through free 6 
radical formation with the capacity to activate signaling pathways that serve to defend 7 
O2 homeostasis in the face of a reduced PO2.  8 
These findings extend previous EPR spin-trapping reports of an increased 9 
cerebrospinal fluid (CSF) concentration (Bailey et al 2006) and net cerebral output of 10 
blood-borne alkoxyl-alkyl radicals during hypoxia (Bailey et al 2009d). In the current 11 
study, we took advantage of A•- as a biomarker to determine the brain’s “global” rate 12 
of free radical flux in-vivo rather than focus on select species trapped ex-vivo whose 13 
individual contributions to the neuro-oxidative cascade remain, as a consequence, 14 
uncertain. Given that the one-electron reduction potential associated with the A•-15 
/ascorbate monanion (AH-) couple is so low (EO΄ = +282mV at pH 7.0), any radical 16 
generated across the cerebral circulation will react endogenously with this terminal 17 
small-molecule antioxidant to form the distinctive doublet A•- that is readily 18 
detectable by EPR [(R• + AH- → A•- + R-H, (Buettner 1993)]. The fact that hypoxia 19 
did not affect ascorbate exchange further emphasizes that the increased output of A•-, 20 
detectable even within the time constraints of a single arterio-venous transit, likely 21 
reflects de-novo radical formation (and not simply increased ascorbate auto-oxidation) 22 
by any number of oxidizing species whose identities remain to be established.    23 
Though beyond the scope of the present study, the source, mechanisms and functional 24 
significance of free radical formation in hypoxia remains to be established. Given its 25 
 14 
modest antioxidant defenses, abundance of catalytic transition metals, auto-oxidizable 1 
neurotransmitters and neuronal membrane lipids rich in polyunsaturated fatty acid 2 
side-chains exposed to a disproportionately high O2 flux, the human brain has 3 
traditionally been considered especially vulnerable to molecular attack (Bailey et al 4 
2009a). To examine this, we measured exchange of the dimeric enzyme NSE, the 5 
neuronal form of the glycolytic enzyme enolase (2-phospho-D-glycerate hydrolase) 6 
which is located almost exclusively within neuronal cell bodies, axons and 7 
neuroendocrine cells (Schmechel et al 1978). Its appearance across the cerebral 8 
circulation would therefore reflect parenchymal tissue injury in direct proportion to 9 
the extent of damage (Schoerkhuber et al 1999). Thus, the lack of exchange observed 10 
in the current study combined with prior reports that have consistently failed to 11 
document any increase in the systemic (Bailey et al 2009b), CSF (Bailey et al 2006) 12 
and trans-cerebral (Bailey et al 2009d) concentration of the astrocytic protein S100β, 13 
a peripheral biomarker of blood-brain barrier damage, confirms that cerebral free 14 
radical formation proceeds in hypoxia without compromizing neurovascular integrity. 15 
As anticipated, hypoxia was associated with AMS and headache with modest 16 
correlations observed between symptom scores and the increased cerebral output of 17 
A•-. Similar correlations have been observed between the rise in (cephalic) venous A•- 18 
and cephalalgia which could be explained, at least in part (≈30% of the variance) by 19 
the reduction in arterial oxyhemoglobin saturation (Bailey et al 2009b). Thus, if AMS 20 
is indeed associated with more marked arterial hypoxemia as previously suggested 21 
(Ge et al 1997), symptoms may simply prove the consequence of more marked 
_
P mitO2 -22 
induced cerebral ROS-RNS formation which although controversial (Bailey et al 23 
2009c), have the capacity to sensitize perivascular sensory nerves and activate 24 
trigeminovascular nocioceptors (Sanchez del Rio and Moskowitz 1999). Follow-up 25 
 15 
exchange studies employing “brain-specific” targeted antioxidants are warranted to 1 
confirm if neuro-oxidative-nitrosative-stress is indeed a causal or merely 2 
consequential event and its corresponding impact on cerebral oxygenation. 3 
These findings force a re-appraisal of free radicals as simply damaging or toxic 4 
“accidents of chemistry” and argue that their formation by the human brain may 5 
represent an adaptive response to hypoxia. It is tempting to speculate that the 6 
increases in CBF and EO2 observed in the current study were subject to redox-7 
regulation and served to maintain global cerebral oxygenation in the face of severe 8 
hypoxemic-hypocapnia. This concept is consistent with earlier work implicating 9 
(mitochondrial) ROS-RNS as signalling molecules that coordinate the intrinsic 10 
mitochondrial cell death pathway in response to a diverse range of cellular stressors 11 
(Wright et al 2004). More recently, in-vitro studies which have identified the electron 12 
transport chain as the primary O2 sensor, with Complex III-derived ROS released to 13 
the inter-membrane space and cytosol as signals capable of triggering transcriptional 14 
and post-translational responses to hypoxia, notably stabilization of HIF-1α, that 15 
ultimately preserve cellular O2 supply (Waypa et al 2010).  In support, antioxidant 16 
prophylaxis was recently associated with a reduction in brachial artery vasodilation in 17 
exercising humans (Richardson et al 2007), further establishing the functional 18 
importance of free radical formation in controlled, though as of yet undefined 19 
amounts.  20 
It is important to recognize that our findings reflect “global” as opposed to “regional” 21 
cerebral responses to hypoxia and the techniques employed lack the temporal 22 
resolution required to assess dynamic change. The regional variation in the CBF 23 
response to acute (albeit isocapnic) hypoxia (8 mins at 10% O2) was confirmed by 24 
H215O positron emission tomography (Binks et al 2008). The authors identified that 25 
 16 
phylogenetically-older structures of the brain (nucleus accumbens, putamen, pallidum, 1 
caudate and thalamus) exhibited greater increases in CBF during hypoxia compared to 2 
evolutionary-younger (cortical) regions which they speculated may represent an 3 
adaptive response that serves to protect regions responsible for (the more) essential 4 
homeostatic functions. Thus, like the skeletal and pulmonary circulatory response to 5 
hypoxia, cerebral tissue is equally defined by marked diffusion-perfusion 6 
heterogeneity and as a consequence, one must therefore assume that the 
_
P mitO2  7 
response to hypoxia follows a similar pattern in that regional variations likely 8 
predominate. 9 
The values obtained for CBF and CMRO2 (and thus by consequence the derivation of 10 
L) were noticeably higher than those reported in previous studies using the same 11 
technique, albeit with 133Xe as the tracer (Madsen et al 1993; Moller et al 2002). The 12 
reasons for this discrepancy are not clear though we remain confident that they were 13 
not caused by the contamination of samples with blood from extra-cerebral regions or 14 
as a consequence of inadequate desaturation.  15 
Extracranial contamination would lead to a higher CBF but would probably not affect 16 
the CMRO2 or even lower the measured values given the low metabolic rate and 17 
oxygen extraction of extra-cranial tissues. This is further supported by the observed 18 
OGIs which would have been expected to be significantly greater than the observed 19 
values of ≈6 given that such tissue would not be expected to be fueled exclusively by 20 
glucose. Finally, in the absence of radiographic evidence, all subjects reported a 21 
“purl” during saline injection into the catheter which indirectly confirms correct line 22 
placement.  23 
In terms of desaturation, since N2O is less soluble in biological tissues than 133Xe 24 
(Kety et al 1948) the corresponding washout phase should theoretically be shorter and 25 
 17 
thus the error of measurement less. Furthermore, the sampling period was expanded 1 
from the original 10 min as applied with 133Xe (Madsen et al 1993; Moller et al 2002) 2 
to 15 min to confirm complete washout. Finally, our choice of N2O as the tracer did 3 
not influence blood-borne nitric oxide (NO) metabolites thus arguing against NO-4 
mediated vasodilatation as a potential contaminant (Taudorf et al 2009). Though the 5 
reasons underlying these atypically high CBF and CMRO2 values remain unknown, 6 
the repeated-measures design ensured precision with our primary interest focused on 7 
the qualitative changes incurred by hypoxia. 8 
In conclusion, the observation that hypoxia triggers a net cerebral output of free 9 
radicals in the absence of neurovascular tissue damage and in direct proportion to the 10 
reduction in
_
P mitO2  provides the first tentative evidence for O2-sensing by the human 11 
brain. It would be of interest to determine if antioxidant prophylaxis ablates the 12 
cerebral adaptive response to hypoxia in future studies.  13 
14 
 18 
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Table 1. Cerebral oxygenation 
 
 Normoxia Hypoxia 
CBF (ml 100g-1min-1) 85 ± 15 94 ± 17 
   
CPF (ml 100g-1min-1) 51 ± 9 57 ± 11 
   
O2 delivery (µmol 100g-1min-1) 728 ± 145 666 ± 108 
   
a-jvDO2 (mmol) 2.8 ± 0.3 2.7 ± 0.4 
   
EO2 (%) 33 ± 3 38 ± 6† 
   
CMRO2 (µmol 100g-1min-1) 243 ± 55 249 ± 34 
   
_
S capO2  (%) 
82.7 ± 1.3 66.9 ± 3.6† 
   
_
P capO2  (mmHg)  
43.3 ± 2.0 33.3 ± 2.0† 
   
_
P mitO2  (mmHg)  
14.6 ± 4.1 1.4 ± 5.5† 
 
Values are mean ± SD; CBF/CPF, cerebral blood/plasma flow; a-jvDO2, arterio-jugular 
venous O2 content difference; EO2, oxygen extraction fraction; CMRO2, cerebral metabolic 
rate of oxygen; 
_
S capO2 , mean capillary O2 saturation; 
_
P capO2 , mean capillary PO2; 
_
P mitO2 , mean 
mitochondrial PO2; †different (P < 0.05). 
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Figure Legends 
 
Figure 1A. Oxidation of the ascorbate monoanion (AH-) by an initiating species (R•) 
with a one electron reduction potential (Eº΄) greater than +282 mV yields the 
domesticated ascorbate radical (A•-). The unpaired electron is delocalized over a 
highly conjugated tri-carbonyl π-system rendering it resonance-stabilized facilitating 
direct detection by electron paramagnetic resonance (EPR) spectroscopy. Note the 
increase in the systemic and cerebral formation of A•- during 9h passive exposure to 
hypoxia. Digits below each spectrum represent EPR signal intensities in arbitrary 
units (double integral which is directly proportional to the concentration of A•-). 
 
Figure 1B. Relationship between the reduction (∆, calculated as the hypoxic minus the 
normoxic control value) in mitochondrial PO2 (
_
P mitO2 ) and increase in the cerebral 
output of ascorbate radicals (A•-).  
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